Novartis, Teva aid Russian police investigation

In an investigation of local drug distributors, Russian police visited Novartis and Teva facilities. The companies are suspected of no wrongdoing. The investigation targets a carve-up by distributors of the market for supplying the state healthcare system with essential drugs, says Reuters.

The government runs a system of subsidized purchases of drugs for low-income citizens. An investigation into the system showed the bulk of state supply contracts, worth more than $2 billion, went to six distribution firms between 2006 and 2008.

Both of the drugmakers are investing hundreds of millions of dollars in the Russian market.

- here's the story
- here's more

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.